Cardea Bio, a manufacturer of graphene-based biosensors and Nanosens, a manufacturer of biosensors using CRISPR-Chip technology. Financial terms were not disclosed. The closing of the proposed transaction is subject to stockholder approval, definitive documents and customary closing conditions. “We’re excited to become part of Cardea and develop new and innovative uses for our combined technologies. To help realize the potential, we’re calling all genomics innovators to join the Early Access Program to accelerate our research and product development" Kiana Aran, Nanosens Co-Founder,